ARCHIVES

NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money.

This article is from The Cancer Letter archive.

Vol. 34 No. 25 | June 27, 2008

Download PDF Visit The Full Archive

Related Articles

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

June 27, 2014

DCPC Board Defers Decision On Hepatitis Vaccine Study, Rejects PAP Sensitivity Concepts

June 1, 1984

DCT Board Approves Concept For BRMP Master Agreement

June 26, 1987

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

July 11, 2014

NCI Moves To Suspend Researcher Amid Charges Contractor Made Mortgage And Other Payments

May 4, 1990

NIH Panel Calls for Further Research On End-of-Life Issues.

January 21, 2005